Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05346198 · UNKNOWN
Trial details
- NCT number
- NCT05346198
- Sponsor
- Shanghai Simnova Biotechnology Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2022-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.